LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.79%14.09B | -2.36%3.44B | -4.78%3.45B | -1.85%3.6B | 6.27%3.6B | 12.37%14.2B | 6.18%3.52B | 12.28%3.62B | -2.34%3.67B | -12.67%3.38B |
Operating revenue | -0.79%14.09B | -2.36%3.44B | -4.78%3.45B | -1.85%3.6B | 6.27%3.6B | 12.37%14.2B | 6.18%3.52B | 12.28%3.62B | -2.34%3.67B | -12.67%3.38B |
Cost of revenue | -1.65%11.44B | -3.74%2.76B | -5.29%2.81B | -2.44%2.92B | 5.17%2.95B | 13.29%11.63B | 6.91%2.86B | 13.40%2.97B | -1.84%2.99B | -10.18%2.81B |
Gross profit | 3.12%2.65B | 3.64%683M | -2.45%636M | 0.74%685M | 11.61%644M | 8.40%2.57B | 3.13%659M | 7.41%652M | -4.49%680M | -23.07%577M |
Operating expense | 2.88%1.36B | -2.52%348M | 3.03%340M | 7.40%363M | 12.59%331M | 2.64%1.32B | 6.57%357M | 1.54%330M | -15.29%338M | -23.44%294M |
Selling and administrative expenses | 2.40%1.36B | -4.08%353M | 3.03%340M | 2.10%341M | 10.30%332M | 3.18%1.33B | 8.55%368M | 1.54%330M | -15.23%334M | -22.42%301M |
-General and administrative expense | 2.40%1.36B | ---- | ---- | 2.10%341M | 10.30%332M | 3.18%1.33B | ---- | ---- | -15.23%334M | --301M |
Other operating expenses | 54.55%-5M | ---- | ---- | 450.00%22M | 85.71%-1M | -175.00%-11M | ---- | ---- | -20.00%4M | -75.00%-7M |
Operating profit | 3.37%1.29B | 10.93%335M | -8.07%296M | -5.85%322M | 10.60%313M | 15.24%1.25B | -0.66%302M | 14.18%322M | 9.27%342M | -22.68%283M |
Net non-operating interest income expense | 21.05%-30M | 62.86%-13M | -121.05%-4M | 33.33%-8M | 50.00%-5M | 25.49%-38M | -250.00%-35M | 258.33%19M | 20.00%-12M | 33.33%-10M |
Non-operating interest income | 54.29%54M | ---- | ---- | 28.57%9M | 42.86%10M | 75.00%35M | ---- | ---- | 16.67%7M | 75.00%7M |
Non-operating interest expense | 15.07%84M | ---- | ---- | -10.53%17M | -11.76%15M | 2.82%73M | ---- | ---- | -9.52%19M | -10.53%17M |
Total other finance cost | ---- | ---- | 121.05%4M | ---- | ---- | ---- | ---- | ---19M | ---- | ---- |
Other net income (expense) | -229.22%-721M | -1,586.84%-641M | 78.64%-22M | 70.37%-16M | 28.00%-18M | -84.03%-219M | 52.50%-38M | -930.00%-103M | -440.00%-54M | 30.56%-25M |
Gain on sale of security | 99.43%-1M | ---- | 103.33%2M | ---- | 86.67%-2M | -138.36%-174M | 2.17%-45M | -6,100.00%-60M | -590.91%-54M | 61.54%-15M |
Earnings from equity interest | -10.00%27M | -42.86%4M | -40.00%6M | 0.00%12M | 400.00%5M | 7.14%30M | 0.00%7M | 100.00%10M | 9.09%12M | -87.50%1M |
Special income (charges) | -896.00%-747M | -16,350.00%-650M | 52.83%-25M | -177.78%-25M | -90.91%-21M | -1.35%-75M | 111.76%4M | -178.95%-53M | 70.97%-9M | 21.43%-11M |
-Less:Restructuring and merger&acquisition | -8.82%93M | -106.25%-1M | -67.24%19M | 177.78%25M | 90.91%21M | 78.95%102M | 700.00%16M | 480.00%58M | -70.97%9M | -71.05%11M |
-Less:Impairment of capital assets | 2,127.59%646M | 3,488.89%646M | --0 | ---- | ---- | -3.33%29M | -40.00%18M | --2M | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---38M | ---- | ---- | ---- | ---- |
-Gain on sale of business | -220.00%-6M | ---3M | ---6M | ---- | ---- | -61.54%5M | --0 | --0 | ---- | ---- |
-Gain on sale of property,plant,equipment | -115.38%-2M | ---2M | --0 | ---- | ---- | --13M | --0 | --7M | ---- | ---- |
Other non- operating income (expenses) | ---- | ---- | ---5M | 0.00%-3M | ---- | ---- | ---- | ---- | -200.00%-3M | ---- |
Income before tax | -45.61%539M | -239.30%-319M | 13.45%270M | 7.97%298M | 16.94%290M | 8.54%991M | 7.01%229M | -8.46%238M | -4.17%276M | -21.27%248M |
Income tax | -61.59%111M | 13.56%67M | -90.23%13M | -203.33%-31M | -7.46%62M | 48.21%289M | 227.78%59M | 95.59%133M | -47.37%30M | -26.37%67M |
Net income | -42.59%399M | -321.71%-388M | 266.18%249M | 42.79%317M | -3.91%221M | -32.26%695M | -37.28%175M | -76.71%68M | -3.90%222M | 2.68%230M |
Net income continuous Operations | -39.03%428M | -327.06%-386M | 144.76%257M | 33.74%329M | 25.97%228M | -2.23%702M | -13.27%170M | -45.31%105M | 6.49%246M | -19.20%181M |
Net income discontinuous operations | -314.29%-29M | -140.00%-2M | 78.38%-8M | 50.00%-12M | -114.29%-7M | -102.27%-7M | -93.98%5M | -137.00%-37M | ---24M | --49M |
Minority interest income | -12.86%61M | -19.05%17M | -16.67%15M | -22.22%14M | 15.38%15M | -14.63%70M | -12.50%21M | -5.26%18M | 20.00%18M | -45.83%13M |
Net income attributable to the parent company | -45.92%338M | -362.99%-405M | 368.00%234M | 48.53%303M | -5.07%206M | -33.79%625M | -39.61%154M | -81.68%50M | -5.56%204M | 8.50%217M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -45.92%338M | -362.99%-405M | 368.00%234M | 48.53%303M | -5.07%206M | -33.79%625M | -39.61%154M | -81.68%50M | -5.56%204M | 8.50%217M |
Basic earnings per share | -43.66%1.51 | -376.35%-1.8521 | 395.24%1.04 | 52.27%1.34 | -2.15%0.91 | -33.17%2.68 | -38.47%0.6702 | -82.05%0.21 | -3.30%0.88 | 10.71%0.93 |
Diluted earnings per share | -43.82%1.5 | -380.62%-1.8521 | 395.24%1.04 | 54.02%1.34 | -3.23%0.9 | -33.08%2.67 | -39.40%0.66 | -81.74%0.21 | -4.40%0.87 | 10.71%0.93 |
Dividend per share | -21.43%0.44 | 0.00%0.11 | 0.00%0.11 | -35.29%0.11 | -35.29%0.11 | -17.65%0.56 | -35.29%0.11 | -35.29%0.11 | 0.00%0.17 | 0.00%0.17 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |